Frontlight ResearchEarly access
Taking people in United StatesPhase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
Key facts
- Who runs it
- Mayo Clinic
- Where
- Jacksonville, La Crosse, Mankato, Rochester, and Scottsdale, United StatesSee the 5 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 1,120 people, planned
- Started
- 15 Sept 2025
- Expected to end
- 1 Sept 2031
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Doxycycline
- Azithromycin
- Record updated
- 24 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- All adult patients (>18 years old) admitted with CAP and receiving a beta-lactam antibiotic plus a form of atypical coverage (azithromycin or doxycycline) in the ED within 12 hours of admission
Who cannot take part
- Allergy or contraindication to the use of either azithromycin or doxycycline (usual clinical practice)
- Corrected QT prolongation (> 450 ms in men and > 460 ms in women)
- High clinical suspicion for Legionella pneumonia
- Antibiotics not for CAP
- Pregnant women (based on clinical assessment as part of standard of care)
- Severe CAP as defined by the ATS/IDSA criteria
- Incarcerated individuals (prisoner)
Where in United States
- Mayo Clinic in FloridaJacksonville, United StatesContact: Swetha Reddy (principal investigator)Not yet recruiting
- Mayo Clinic Health System-La CrosseLa Crosse, United StatesContact: Melissa K Myers (principal investigator)Not yet recruiting
- Mayo Clinic Health System MankatoMankato, United StatesContact: Mohamad El Labban (principal investigator)Not yet recruiting
- Mayo Clinic in RochesterRochester, United StatesContact: Amy AmsbaughTaking people
- Mayo Clinic in ArizonaScottsdale, United StatesContact: Cyril Varghese (principal investigator)Not yet recruiting
About the trial
What the trial wants to find out
The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
The 2 groups in the trial
- Doxycycline groupExisting treatment, for comparison
Subjects hospitalized for community acquired pneumonia will receive standard of care treatment with Doxycycline
Treatment: Doxycycline
- Azithromycin groupExisting treatment, for comparison
Subjects hospitalized for community acquired pneumonia will receive standard of care treatment with Azithromycin
Treatment: Azithromycin
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 September 2026